The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2281–2304 of 3,535
A4M's Longevity SpringFest 2026 recently attracted over 3,000 practitioners, marking a record-breaking attendance for the organization. The event featured more...
Remix Therapeutics has announced the acceptance of final results from the Phase 1 dose-escalation cohort of the ARIA study, which evaluates the MYB mRNA degrade...
Xeltis has announced promising 12-month clinical data from its pivotal trial of **aXess™**, a novel implant designed for hemodialysis vascular access, which sho...
Black Diamond Therapeutics has announced significant advancements in the clinical evaluation of **silevertinib**, a fourth-generation tyrosine kinase inhibitor...
The **Global Virus Network (GVN)** has reported a significant resurgence of **measles** in the United States and globally, with over **1,700 cases** recorded in...
BioAge Labs, Inc. has announced promising Phase 1 clinical trial results for **BGE-102**, a novel small molecule NLRP3 inhibitor designed to target inflammation...
Ray Therapeutics has successfully closed a **$125 million Series B financing**, significantly oversubscribed and led by Janus Henderson Investors, with continue...
ACTG has launched the **HoT study** (A5424), a pivotal phase 4 clinical trial aimed at evaluating the **safety and efficacy of menopausal hormone therapy** for...
**Life Extension has launched Advanced Male Sexual Support, a scientifically formulated supplement designed to enhance multiple aspects of male sexual health, i...
Disc Medicine, Inc. has announced the upcoming presentation of data from the **RALLY-MF Phase 2 trial** of **DISC-0974**, an anti-hemojuvelin antibody aimed at...
ImPact Biotech is advancing its clinical pipeline with updates on **Padeliporfin vascular-targeted photodynamic therapy (VTP)**, particularly in the **Phase 3 E...
Nanjing Leads Biolabs Co., Ltd. has initiated a Phase II clinical trial for **Opamtistomig (LBL-024)**, a bispecific antibody targeting PD-L1 and 4-1BB, aimed a...
The **Lachine Hospital Foundation** successfully raised **$322,115** during its annual gala, contributing to the **Dream Big: Lachine Hospital campaign** aimed...
The recent Gala de la Fondation de l’Hôpital de Lachine successfully raised **$322,115** to support the **Osez rêver** campaign, a collaborative initiative aime...
The **Panorama France HealthTech 2026** report reveals a robust landscape of nearly **2,800 innovative companies** in France's HealthTech sector, showcasing res...
Akari Therapeutics has announced the acceptance of its abstract for the ASCO Annual Meeting 2026, detailing the **combination synergy of its spliceosome modulat...
Brain Cancer Canada (BCC) is launching a nationwide campaign for Brain Cancer Awareness Month this May, focusing on increasing visibility and funding for brain...
A recent study published in the *Journal of Clinical Microbiology* by the Bay Area Lyme Foundation reveals significant shortcomings in the diagnostic methods fo...
**Twentyeight Health** has launched **Complete Care**, a pioneering insurance-enabled membership model aimed at providing **unlimited, real-time access** to com...
bioLytical Laboratories Inc. has announced a strategic partnership with the Together TakeMeHome program to enhance access to **HIV self-testing** across the Uni...
**MDNA113, a novel bifunctional Superkine developed by Medicenna Therapeutics, has demonstrated exceptional selectivity and potency in targeting tumors while ma...
**LeonaBio, Inc.** recently showcased promising nonclinical data on **lasofoxifene** at the **AACR26**, presented by researchers from Virginia Commonwealth Univ...
KALA BIO, Inc. has announced a significant policy shift following the Executive Order signed by President Donald J. Trump on April 18, 2026, which prioritizes t...
Rezolute, Inc. has announced that the **Phase 3 sunRIZE study** results for **ersodetug**, a monoclonal antibody aimed at treating congenital hyperinsulinism (H...
